Preparation of diblock copolymers consisting of methoxy poly(ethylene glycol) and poly(ε‐caprolactone)/poly(L‐lactide) and their degradation property
Methoxy poly (ethylene glycol)‐b‐poly (ε‐caprolactone)(MPEG‐PCL) or MPEG‐b‐poly (l‐
lactide)(MPEG‐PLLA) diblock copolymers were prepared by the polymerization of CL or LA …
lactide)(MPEG‐PLLA) diblock copolymers were prepared by the polymerization of CL or LA …
[PDF][PDF] Sibutramine release behavior from microspheres prepared by spray-dry method
JS Park, JS Oh, JM Oh, YT Kim, JH Lee, JH Mo… - Polymer (Korea …, 2008 - koreascience.kr
Sibutramine is a highly crystalline and poorly water soluble drug as the appetite depressant
for obesity treatment. In order to increase water solubility of sibutramine, microspheres …
for obesity treatment. In order to increase water solubility of sibutramine, microspheres …
Characterization and controlled release of solid dispersed sibutramine
JS Park, J Ku, JH Lee, YT Kim, JH Park… - Journal of …, 2008 - koreascience.kr
Solid dispersions of poorly water-soluble drug, sibutramine, were prepared with hydrophilic
polymer, poly-N-vinylpyrrolidone (PVP), hydroxypropylmethylcellulose (HPMC) and organic …
polymer, poly-N-vinylpyrrolidone (PVP), hydroxypropylmethylcellulose (HPMC) and organic …
Development of biodegradable methoxy poly (ethyleneglycol)-polyesters diblock copolymers as drug carrier for implantable disc
The main objective of this study is to investigate the feasibility of methoxy polyethyleneglycol
(mPEG) and poly (D, L-lactide-co-glycolide)(PLGA) or poly (ε-caprolactone)(PCL) diblock …
(mPEG) and poly (D, L-lactide-co-glycolide)(PLGA) or poly (ε-caprolactone)(PCL) diblock …
분무건조방법으로제조된미립구에서Sibutramine 의방출거동
박정수， 오정수， 오재민， 김윤태， 이준희， 모종현… - 폴리머, 2008 - dbpia.co.kr
시부트라민 t 비만을 치료하기 위한 식욕억제제로서 높은 결정성을 갖는 난용성 r 물이다.
이러한 난용성 약물의 용해도를 증가시키기 위하여 고체분산법을 바탕으로 한 분무건조기를 …
이러한 난용성 약물의 용해도를 증가시키기 위하여 고체분산법을 바탕으로 한 분무건조기를 …
Injectable chitosan carrier for demineralized bone matrix
In this study, we developed an injectable carrier for demineralized bone matrix (DBM) which
consists of chitosan and glycerol phosphate (GP). The phase transition behaviors of …
consists of chitosan and glycerol phosphate (GP). The phase transition behaviors of …
[PDF][PDF] PLGA 분자량에따른이중층독소루비신미립구의방출거동
박정수， 양재찬， 육순홍， 신형식， 이종문… - Polymer …, 2007 - researchgate.net
PLGA 분자량에 따른 이중층 독소루비신 미립구의 방출거동 Page 1 Polymer (Korea), Vol. 31,
No. 3, pp 189-193, 2007 PLGA 분자량에 따른 이중층 독소루비신 미립구의 방출거동 박정수 …
No. 3, pp 189-193, 2007 PLGA 분자량에 따른 이중층 독소루비신 미립구의 방출거동 박정수 …
Release behavior of 5-FU from 5-FU/PLGA wafer using recrystallized PLGA and monomer
JS Park, MK Choi, YT Kim, JH Lee, JH Mo… - Korean Chemical …, 2008 - koreascience.kr
Abstract Poly (D, L-lactide-co-glycolide)(PLGA) has been widely used as carriers in
controlled release delivery systems due to its biodegradability and relatively good …
controlled release delivery systems due to its biodegradability and relatively good …
삼차원폴리카프로락톤스캐폴드의산소및질소플라즈마표면처리에따른조골모세포의증식에관한연구
장정익 - 2014 - oak.chosun.ac.kr
Polycaprolactone (PCL) was used as biomaterial in bone tissue engineering. However
drawbacks of these scaffolds derived from the intrinsic hydrophobicity represents low cell …
drawbacks of these scaffolds derived from the intrinsic hydrophobicity represents low cell …
PVP 분자량에따른염산메트포르민정제의특성및방출거동
김대성， 성경열， 김원， 홍희경， 안식일， 박종학… - 조직공학과재생 …, 2009 - kiss.kstudy.com
In this study, metformin HCl, a highly water soluble anti-hyperglycemic agent was prepared
into tablet type with PVP of various molecular weights (Mw) to effective oral administration …
into tablet type with PVP of various molecular weights (Mw) to effective oral administration …